Vertaling van "discussion papers on other " (Nederlands → Frans) :

-- Discussion papers on other important organs to be considered when developing a medicinal products in neonates complementary to the paper already published on renal maturation (e.g. hepatic central nervous system)
-- Discussion papers on other important organs to be considered when developing a medicinal products in neonates complementary to the paper already published on renal maturation (e.g. hepatic, central nervous system)

a- Discussion paper « Vaccination of poultry against highly pathogenic avian influenza H5N1 (DIVA Strategy) » 02.02.06 , SANCO/10103/2006 rev.1
a- Discussion paper « Vaccination of poultry against highly pathogenic avain influenza H5N1 (DIVA Strategy) » 02.02.06 , SANCO/10103/2006 rev.1

Two papers published by Holmberg 12 and Freedman 13 and discussing the interpretation of evidence were found.
Two papers published by Holmberg 13 and Freedman 14 and discussing the interpretation of evidence were found.

The discussion groups receive both substantive and logistical support thanks to organising of training and “intervision” sessions for those coaching these groups and the writing and distributing of a booklet entitled “De Wegwijzer” (the Signpost), which contains, among other things, an inventory of all the self-help and discussion groups for those bereaved by suicide.
Les groupes de discussion reçoivent un soutien logistique et au niveau du contenu, grâce à l’organisation de formations et de moments d’intervision pour ceux qui encadrent ces groupes, et par l’élaboration et la distribution de la brochure « De WegWijzer » qui contient entre autre un inventaire de tous les groupes d’entraide et de discussion pour les proches après un suicide.

Two others papers from Heyes were found by reference searching 25, 50 .
Two others papers from Heyes were found by reference searching 26, 52 .

“We encourage caregivers and health care professionals to discuss these changes and any others during regular visits”.
“ We encourage caregivers and health care professionals to discuss these changes and any others during regular visits”.

As also discussed in notes 9 and 10 of the 2008 Annual Report, other intangible assets and investments in associated companies are reviewed for impairment whenever an event or decision occurs that raises concern about their balance sheet carrying value.
Comme le notent également les annexes 9 et 10 du Rapport annuel 2008, les autres immobilisations incorporelles et investissements dans des sociétés associées font l’objet d’un test de dépréciation dès lors qu’un événement ou une décision les concernant suscitent des doutes quant à leur valeur inscrite au bilan.

At this time, Novartis is unable to assess with any reasonable certainty the likely outcomes, which may be material, of the discussions regarding Trileptal or the inquiry regarding the other five products.
A ce stade, Novartis est dans l’impossibilité d’évaluer, avec un degré de certitude raisonnable, l’issue probable, susceptible d’être matérielle, des discussions concernant Trileptal ou les investigations sur les cinq autres produits.